Efficacy and Safety of Regorafenib Versus Dinutuximab With Chemotherapy in Chinese Children With Neuroblastoma. Bangladesh J Pharmacol 2019, 14 (1), 32-35. https://doi.org/10.3329/bjp.v14i1.38807.